Hematología y Hemoterapia

Resultados: 419
Tipo Título / Nombre Autor(es) Año
Análisis de la expresión de CD38 en las células CD34+ de médula ósea(MO) como prueba útil en los síndromes mielodisplásicos(SMD) Bañas Llanos María H, Casas Avilés I, Ibáñez Espacio F, Bergua Burgués J.M, Arcos Carmona MJ, Martín Mateos M.L, et al 2014
Azacitidine in older patients with acute Myeloid leukemia (AML) and adverse karyotype. Subanalisis from the Alma Study Falantes J, Deben G, Martinez Robles V, Bargay J, Salamero O, Pedro C, et al 2014
Novel assay for ex vivo evaluation of antiproliferative effect of hypomethylating agents 5-Azacytidine and Decitabine in AML patient samples Hernández P, Montesinos P, Serrano J, Herrera P, Bergua J, Colorado M, et al 2014
A prognostic index for patients with refractory or in first relapsed acute myeloid leukemia treated with FLAG-Ida or Flago-Ida Bergua JM, Montesinos P, Martinez-Cuadrón D, Fernández-Abellán P, Serrano J, Sayas MJ, et al 2014
GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators? Mateos MV, Oriol A, Martínez-López J, Teruel AI, López de la Guía A, López J, et al 2014
Observational Prospective Registry for the Assessment of the Clinical Impact of Starting Anti-Myeloma Treatment at Biological Relapse Alegre A, Gironella M, Bergua JM, González E, Esacalante F, Soler A, et al 2014
Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA Ribera JM, Oriol A, Morgades M, Montesinos P, Sarrà J, González-Campos J, et al 2014
Safety of a new high purity factor X concentrate in the management of hereditary factor X deficiency Norton M, Mitchell WB, Álvarez MT, Austin S, Auerswald G, Bermejo N, et al 2014
Efficacy and safety of a new high purity factor X concentrate in the treatment of severe or moderate factor X deficiency Kavalñ K, Austin S, Álvarez MT, Auerswald G, Bermejo N, Mitchell W [et.al], et al 2014
Pharmacokinetics of a new high purity factor X concentrate in subjects with severe or moderate factor X deficiency Austin S, Álvarez MT, Auerswald G, Bermejo N, Kavakli K, Mitchell W, et al 2014